SIS
ORGO icon

Strategic Investment Solutions’s Organogenesis Holdings ORGO Stock Holding History

Strategic Investment Solutions’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43K Hold
1,000
– – ﹤0.01% 580
2026
Q1 		$2.37K Hold
1,000
– – ﹤0.01% 551
2025
Q4 		$5.18K Hold
1,000
– – ﹤0.01% 472
2025
Q3 		$4.22K Buy
+1,000
New +$4.65K ﹤0.01% 463

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Strategic Investment Solutions's ORGO Position: Q2 2026 in Review

Strategic Investment Solutions held its Organogenesis Holdings (ORGO) position steady in Q2 2026 at 1,000 shares worth $2.43K. The position accounts for ﹤0.01% of the portfolio, ranked #580.

Strategic Investment Solutions first reported a position in ORGO in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.18K in Q4 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Strategic Investment Solutions held 1,000 shares of Organogenesis Holdings worth $2.43K as of Q2 2026.
  • Strategic Investment Solutions left its Organogenesis Holdings share count unchanged in Q2 2026.
  • Organogenesis Holdings made up ﹤0.01% of Strategic Investment Solutions's portfolio in Q2 2026, its #580 holding.
  • Strategic Investment Solutions first reported a position in Organogenesis Holdings in Q3 2025 and has held it in 4 quarters since.
  • Strategic Investment Solutions's Organogenesis Holdings position peaked at $5.18K in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.